Mesoblast LtdNASDAQ:MESO
- LAST PRICE10.6350
- TODAY'S CHANGE (%)0.5950 (5.9263%)
- Bid / Lots10.5200/ 20
- Ask / Lots10.7000/ 8
- Open / Previous Close10.4400 / 10.0400
- Day Range
- 52 Week Range
- Volume361,293
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MESO |
|---|---|---|
| 09:32 ET | 7770 | 10.46 |
| 09:33 ET | 1007 | 10.2004 |
| 09:44 ET | 4800 | 10.3 |
| 09:46 ET | 3456 | 10.315 |
| 09:48 ET | 800 | 10.275 |
| 09:50 ET | 2550 | 10.26 |
| 09:53 ET | 4102 | 10.3 |
| 09:55 ET | 200 | 10.295 |
| 09:57 ET | 2005 | 10.34 |
| 10:00 ET | 550 | 10.3553 |
| 10:02 ET | 550 | 10.34 |
| 10:06 ET | 1000 | 10.34 |
| 10:08 ET | 100 | 10.31 |
| 10:11 ET | 2270 | 10.275 |
| 10:13 ET | 200 | 10.275 |
| 10:18 ET | 2786 | 10.33 |
| 10:20 ET | 200 | 10.375 |
| 10:33 ET | 1112 | 10.3862 |
| 10:36 ET | 4540 | 10.45 |
| 10:38 ET | 5945 | 10.5 |
| 10:42 ET | 3854 | 10.43 |
| 10:44 ET | 3354 | 10.51 |
| 10:45 ET | 10215 | 10.5 |
| 10:49 ET | 1400 | 10.4704 |
| 10:51 ET | 191 | 10.495 |
| 10:54 ET | 650 | 10.49 |
| 10:56 ET | 9100 | 10.535 |
| 10:58 ET | 100 | 10.52 |
| 11:00 ET | 654 | 10.555 |
| 11:02 ET | 3200 | 10.5574 |
| 11:03 ET | 3369 | 10.55 |
| 11:05 ET | 1125 | 10.55 |
| 11:07 ET | 100 | 10.5 |
| 11:09 ET | 1500 | 10.545 |
| 11:12 ET | 6750 | 10.5 |
| 11:14 ET | 500 | 10.5131 |
| 11:16 ET | 752 | 10.51 |
| 11:18 ET | 1636 | 10.56 |
| 11:21 ET | 3400 | 10.55 |
| 11:23 ET | 3047 | 10.57 |
| 11:27 ET | 776 | 10.62 |
| 11:32 ET | 600 | 10.5501 |
| 11:34 ET | 3019 | 10.72 |
| 11:36 ET | 600 | 10.725 |
| 11:38 ET | 582 | 10.71 |
| 11:39 ET | 1895 | 10.75 |
| 11:41 ET | 5295 | 10.665 |
| 11:43 ET | 900 | 10.665 |
| 11:45 ET | 5400 | 10.665 |
| 11:48 ET | 700 | 10.665 |
| 11:52 ET | 1900 | 10.69 |
| 11:54 ET | 1549 | 10.76 |
| 11:56 ET | 663 | 10.69 |
| 12:01 ET | 321 | 10.69 |
| 12:03 ET | 113 | 10.68 |
| 12:08 ET | 2434 | 10.77 |
| 12:12 ET | 12913 | 10.7 |
| 12:15 ET | 2342 | 10.7 |
| 12:17 ET | 1600 | 10.705 |
| 12:19 ET | 10460 | 10.7 |
| 12:21 ET | 20105 | 10.61 |
| 12:24 ET | 2100 | 10.61 |
| 12:28 ET | 213 | 10.5468 |
| 12:32 ET | 1971 | 10.6599 |
| 12:33 ET | 281 | 10.54 |
| 12:35 ET | 100 | 10.64 |
| 12:44 ET | 100 | 10.595 |
| 12:46 ET | 10200 | 10.65 |
| 12:48 ET | 100 | 10.65 |
| 12:50 ET | 600 | 10.62 |
| 12:51 ET | 100 | 10.63 |
| 12:55 ET | 100 | 10.63 |
| 01:00 ET | 933 | 10.64 |
| 01:04 ET | 200 | 10.66 |
| 01:08 ET | 1100 | 10.64 |
| 01:09 ET | 300 | 10.65 |
| 01:13 ET | 734 | 10.71 |
| 01:15 ET | 100 | 10.71 |
| 01:18 ET | 7500 | 10.6 |
| 01:20 ET | 8168 | 10.65 |
| 01:27 ET | 1200 | 10.58 |
| 01:31 ET | 600 | 10.608 |
| 01:38 ET | 1451 | 10.63 |
| 01:40 ET | 700 | 10.56 |
| 01:44 ET | 100 | 10.63 |
| 01:54 ET | 103 | 10.65 |
| 01:56 ET | 1585 | 10.6201 |
| 01:58 ET | 475 | 10.6 |
| 02:00 ET | 700 | 10.63 |
| 02:07 ET | 450 | 10.6 |
| 02:14 ET | 256 | 10.5492 |
| 02:25 ET | 100 | 10.6 |
| 02:27 ET | 500 | 10.6 |
| 02:32 ET | 300 | 10.57 |
| 02:36 ET | 100 | 10.57 |
| 02:43 ET | 527 | 10.6 |
| 02:45 ET | 100 | 10.61 |
| 02:50 ET | 1131 | 10.63 |
| 02:54 ET | 100 | 10.65 |
| 03:01 ET | 930 | 10.65 |
| 03:03 ET | 510 | 10.65 |
| 03:06 ET | 2000 | 10.64 |
| 03:14 ET | 100 | 10.5944 |
| 03:17 ET | 209 | 10.66 |
| 03:19 ET | 510 | 10.6 |
| 03:21 ET | 900 | 10.66 |
| 03:24 ET | 4100 | 10.67 |
| 03:30 ET | 700 | 10.65 |
| 03:32 ET | 5272 | 10.69 |
| 03:33 ET | 13000 | 10.69 |
| 03:35 ET | 923 | 10.68 |
| 03:42 ET | 1000 | 10.646 |
| 03:44 ET | 825 | 10.67 |
| 03:46 ET | 100 | 10.675 |
| 03:48 ET | 100 | 10.7 |
| 03:50 ET | 1762 | 10.71 |
| 03:51 ET | 1000 | 10.65 |
| 03:53 ET | 1200 | 10.61 |
| 03:57 ET | 18560 | 10.62 |
| 04:00 ET | 24657 | 10.635 |
Oct 30, 2024
Press Release: Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024, from 7:11PM ET on Wednesday Oct 30, 2024 by Dow Jones
7:11PM ET on Wednesday Oct 30, 2024 by Dow JonesAppendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024, from 7:11PM ET on Wednesday Oct 30, 2024 by Dow Jones
7:11PM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mesoblast Ltd | 1.2B | -12.1x | --- |
Pharvaris NV | 1.1B | -7.7x | --- |
Enliven Therapeutics Inc | 1.2B | -13.1x | --- |
Kura Oncology Inc | 1.2B | -6.8x | --- |
Rocket Pharmaceuticals Inc | 1.3B | -5.0x | --- |
Cassava Sciences Inc | 1.3B | -74.1x | --- |
Company Information
Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.
Contact Information
- Headquarters
- L 38 55 Collins StMELBOURNE, VIC, Australia 3000
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Jane Bell
- Chief Executive Officer, Executive Director
- Silviu Itescu
- Non-Executive Independent Vice Chairman of the Board
- William Burns
- Interim Chief Financial Officer
- Andrew Chaponnel
- Senior Vice President, Head - Translational Research
- Fiona See
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $5.9M |
Shares Outstanding | 114.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.50 |
EPS | $-0.88 |
Book Value | $4.21 |
P/E Ratio | -12.1x |
Price/Sales (TTM) | 196.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,173.11% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
